Which has the lower trailing P/E, EW or IQV?

IQV has the lower trailing P/E: EW trades at 51.60 and IQV at 32.24. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, EW or IQV?

Over the past five years, EW grew revenue faster — EW at a 5.75% CAGR versus IQV at 5.61%.

Is EW or IQV more profitable?

EW runs the higher net margin — EW at 15.43% versus IQV at 8.10%.

How have EW and IQV total returns compared?

Over the past 10 years, EW delivered 8.59% and IQV delivered 13.22% annualized total return. Past performance doesn't predict future results.

Edwards Lifesciences Corporation (EW) vs IQVIA Holdings Inc. (IQV)

A side-by-side comparison of Edwards Lifesciences Corporation and IQVIA Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 23, 2026. Differences are shown without an overall score or investment verdict.

Edwards Lifesciences Corporation

$51.70B

$89.79HealthcareAt close: Aug 21, 2026, 4:00 PM ET

IQV

IQVIA Holdings Inc.

$42.77B

$259.82HealthcareAt close: Aug 21, 2026, 4:00 PM ET

Total return — EW vs IQV

growth of $100 · dividends reinvested · last 10y

EW +138.9% (+9.1%/yr)IQV +239.2% (+13.0%/yr)IQV compounded faster over this window

EW IQV

EW vs IQV: by the numbers

•EW is the larger company ($51.70B vs $42.77B market cap).
•IQV trades at the lower trailing earnings multiple (32.24 vs 51.60 P/E), one valuation lens rather than an overall verdict.
•EW converts more revenue to profit (15.43% vs 8.10% net margin).
•EW grew revenue faster over the past five years (5.75% vs 5.61% CAGR).

Metrics side by side

Valuation

Metric	EW	IQV
P/E ratio	51.60	32.24
Forward P/E	29.92	20.04
P/S ratio	7.96	2.58
P/B ratio	4.88	7.10
EV / EBITDA	24.89	16.67
FCF yield	2.76%	5.97%

Profitability

Metric	EW	IQV
Gross margin	77.98%	26.23%
Operating margin	28.09%	13.57%
Net margin	15.43%	8.10%
ROE	9.46%	22.28%
ROIC	10.22%	8.32%

Growth (annualized)

Metric	EW	IQV
Revenue CAGR (5Y)	5.75%	5.61%
EPS CAGR (5Y)	6.87%	40.21%
FCF CAGR (5Y)	6.41%	4.44%
Total return CAGR (5Y)	-5.47%	0.40%

Frequently asked

Which has the lower trailing P/E, EW or IQV?: IQV has the lower trailing P/E: EW trades at 51.60 and IQV at 32.24. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, EW or IQV?: Over the past five years, EW grew revenue faster — EW at a 5.75% CAGR versus IQV at 5.61%.
Is EW or IQV more profitable?: EW runs the higher net margin — EW at 15.43% versus IQV at 8.10%.
How have EW and IQV total returns compared?: Over the past 10 years, EW delivered 8.59% and IQV delivered 13.22% annualized total return. Past performance doesn't predict future results.

Go deeper

Full EW analysis Full IQV analysis Interactive comparison tool

Dig into the metrics

Edwards Lifesciences P/E ratio IQVIA P/E ratio Edwards Lifesciences ROE IQVIA ROE Edwards Lifesciences operating margin IQVIA operating margin Edwards Lifesciences revenue growth IQVIA revenue growth Edwards Lifesciences free cash flow IQVIA free cash flow

Edwards Lifesciences & IQVIA appear in these rankings

Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 23, 2026.